NMTC News and Press, NeuroOne Medical Technologies Corporation From 07/12/22

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode PR Newswire Case performed at Emory University for intraoperative brain mapping EDEN PRAIRIE, Minn. , July 12, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corpo...

NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders PR Newswire Letter recaps key highlights of fiscal year 2021 and features upcoming milestones for fiscal year 2022 and beyond EDEN PRAIRIE, Minn. , Jun...

Gainers: Tonix Pharmaceuticals Holding (TNXP) +60%. Helius Medical Technologies (HSDT) +40%. View (VIEW) +42%. Spark Networks (LOV) +32%. Regencell Bioscience Holdings (RGC) +21%. 180 Life Sciences (ATNF) +20%. Evelo Biosciences (EVLO) +17%. NeuroOne Medical Technologies Corporation (NMTC) +1...

Gainers: Helius Medical Technologies (HSDT) +57%. Tonix Pharmaceuticals  TNXP +49%. NeuroOne Medical Technologies (NMTC) +16%. Oncternal Therapeutics (ONCT) +16%. Butterfly Network (BFLY) +15%. Losers: Enochian Biosciences ENOB -37%. Icosavax ...

Tonix Pharmaceuticals TNXP +31% on U.S. patent win for monkeypox vaccine technology. View VIEW +15% on FY results. Rail Vision (RVSN) +13% receives Japanese patent allowance for railway obstacle detection technology. Victoria's Secret VSCO +10% on Q1 results...

NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25 PR Newswire EDEN PRAIRIE, Minn. , May 19, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NA...

NeuroOne Provides Evo® sEEG Update PR Newswire The Evo® sEEG electrode 510(k) cleared for temporary (less than 24 hours) use remains in effect and the Company will explore the opportunity to market the device for intraoperative use. EDEN PRAIRIE...

NeuroOne Medical Technologies Corporation (NMTC) Q2 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Dave Rosa – Chief Executive Officer Ron Mcclurg – Chief Financial Officer Conference Call Participants Connor Stevenson – Craig-Hallum Ben Haynor...

NeuroOne Medical Technologies Corporation press release (NASDAQ:NMTC): FQ2 Net Loss of $3.1M, compared to $2.4M in the year-ago period. The company had cash of $12.9M as of Mar. 31. Shares +1.2%. For further details see: NeuroOne Medical FQ2 Net Loss of $3.1M

NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update PR Newswire EDEN PRAIRIE, Minn. , May 12, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medic...